662 related articles for article (PubMed ID: 18477800)
21. Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients.
Moten AS; Zhao H; Intenzo CM; Willis AI
Eur J Surg Oncol; 2019 Nov; 45(11):2090-2095. PubMed ID: 31253543
[TBL] [Abstract][Full Text] [Related]
22. Racial Disparities in the Receipt of Guideline Care and Cancer Deaths for Women with Ovarian Cancer.
Cronin KA; Howlader N; Stevens JL; Trimble EL; Harlan LC; Warren JL
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):539-545. PubMed ID: 30487136
[TBL] [Abstract][Full Text] [Related]
23. Impact of referral patterns on the use of chemotherapy for lung cancer.
Earle CC; Neumann PJ; Gelber RD; Weinstein MC; Weeks JC
J Clin Oncol; 2002 Apr; 20(7):1786-92. PubMed ID: 11919235
[TBL] [Abstract][Full Text] [Related]
24. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer.
Luo R; Giordano SH; Freeman JL; Zhang D; Goodwin JS
Oncologist; 2006 Oct; 11(9):1025-33. PubMed ID: 17030645
[TBL] [Abstract][Full Text] [Related]
25. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
Eldin NS; Yasui Y; Scarfe A; Winget M
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
[TBL] [Abstract][Full Text] [Related]
26. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
27. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
[TBL] [Abstract][Full Text] [Related]
28. Disparities in Use of Human Epidermal Growth Hormone Receptor 2-Targeted Therapy for Early-Stage Breast Cancer.
Reeder-Hayes K; Peacock Hinton S; Meng K; Carey LA; Dusetzina SB
J Clin Oncol; 2016 Jun; 34(17):2003-9. PubMed ID: 27069085
[TBL] [Abstract][Full Text] [Related]
29. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
[TBL] [Abstract][Full Text] [Related]
30. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
31. Application of the nonlinear Blinder-Oaxaca decomposition to study racial/ethnic disparities in antiobesity medication use in the United States.
Mehta HB; Rajan SS; Aparasu RR; Johnson ML
Res Social Adm Pharm; 2013; 9(1):13-26. PubMed ID: 22554395
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.
Griggs JJ; Hawley ST; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Mujahid MS; Friese CR; Salem B; Abrahamse PH; Katz SJ
J Clin Oncol; 2012 Sep; 30(25):3058-64. PubMed ID: 22869890
[TBL] [Abstract][Full Text] [Related]
34. Rectal cancer: changing patterns of referral for radiation therapy 1982-1997.
Stevens G; Firth I; Solomon M; Saw R; Glenn D; Eyers A; West R
Aust N Z J Surg; 2000 Aug; 70(8):553-9. PubMed ID: 10945546
[TBL] [Abstract][Full Text] [Related]
35. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
36. Racial disparities in the use of revascularization before leg amputation in Medicare patients.
Holman KH; Henke PK; Dimick JB; Birkmeyer JD
J Vasc Surg; 2011 Aug; 54(2):420-6, 426.e1. PubMed ID: 21571495
[TBL] [Abstract][Full Text] [Related]
37. Racial disparities in late survival after rectal cancer surgery.
Morris AM; Wei Y; Birkmeyer NJ; Birkmeyer JD
J Am Coll Surg; 2006 Dec; 203(6):787-94. PubMed ID: 17116545
[TBL] [Abstract][Full Text] [Related]
38. Impact of affordable care act on the treatment and outcomes for stage-IV colorectal cancer.
Jayakrishnan TT; Bakalov V; Chahine Z; Finley G; Monga D; Wegner RE
Cancer Treat Res Commun; 2020; 24():100204. PubMed ID: 32805532
[TBL] [Abstract][Full Text] [Related]
39. Racial Disparities in Resection of Early Stage Non-Small Cell Lung Cancer: Variability Among Surgeons.
Ezer N; Mhango G; Bagiella E; Goodman E; Flores R; Wisnivesky JP
Med Care; 2020 Apr; 58(4):392-398. PubMed ID: 31895307
[TBL] [Abstract][Full Text] [Related]
40. Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality.
Haas JS; Brawarsky P; Iyer A; Fitzmaurice GM; Neville BA; Earle C
Cancer; 2011 Sep; 117(18):4267-76. PubMed ID: 21413000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
